Telomerase-activating tetrapeptide derived from pineal gland epithalamin. Over 30 years of research showing telomere elongation and lifespan extension in preclinical models.
Epithalon, Epithalone, Epithalamin (natural form), Ala-Glu-Asp-Gly

Short (minutes); effects persist for weeks/months after treatment cycles
Epitalon (epithalon, epithalone) is a synthetic tetrapeptide based on the natural peptide epithalamin, which is produced by the pineal gland. Discovered by Russian gerontologist Professor Vladimir Khavinson, epitalon is the most extensively studied peptide in the field of telomere biology and anti-aging research, with over 30 years of research data.
Epitalon activates telomerase, the enzyme responsible for maintaining and elongating telomeres — the protective caps on the ends of chromosomes. Telomere shortening is a fundamental mechanism of cellular aging; when telomeres reach a critical length, cells enter senescence or apoptosis. By reactivating telomerase in somatic cells, epitalon may help restore telomere length and extend the replicative potential of cells.
Additionally, epitalon regulates melatonin production by the pineal gland, helping normalize circadian rhythms that deteriorate with age. It also modulates neuroendocrine function and has been shown to influence gene expression related to antioxidant defense and protein synthesis.
Khavinson et al. have published extensive research on epitalon spanning decades. Key findings include: telomerase activation in human fetal fibroblasts and retinal pigment epithelium cells, extension of mean lifespan by 13.3% in animal models, restoration of melatonin secretion rhythms in aged primates, and improvement of retinal function in age-related retinal degeneration.
A notable study by Khavinson and Morozov demonstrated that epitalon elongated telomeres in human blood cells. Further research showed that epitalon increased the Hayflick limit (maximum number of cell divisions) of human somatic cells beyond the normal threshold, suggesting direct anti-senescence activity.
While the majority of published research originates from Russian institutions, the body of evidence is substantial, with over 100 peer-reviewed publications. However, large-scale Western clinical trials are lacking.
390.35 g/mol
Ala-Glu-Asp-Gly
Class
Research Status
PreclinicalHalf-Life
Short (minutes); effects persist for weeks/months after treatment cycles
Routes
Category
Longevity & Anti-Aging